Eterna Therapeutics Balance Sheet Health
Financial Health criteria checks 2/6
Eterna Therapeutics has a total shareholder equity of $2.2M and total debt of $6.8M, which brings its debt-to-equity ratio to 303.3%. Its total assets and total liabilities are $49.1M and $46.9M respectively.
Key information
303.3%
Debt to equity ratio
US$6.77m
Debt
| Interest coverage ratio | n/a |
| Cash | US$7.58m |
| Equity | US$2.23m |
| Total liabilities | US$46.90m |
| Total assets | US$49.13m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: ERNA's short term assets ($9.6M) exceed its short term liabilities ($6.6M).
Long Term Liabilities: ERNA's short term assets ($9.6M) do not cover its long term liabilities ($40.3M).
Debt to Equity History and Analysis
Debt Level: ERNA has more cash than its total debt.
Reducing Debt: ERNA's debt to equity ratio has increased from 4% to 303.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ERNA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ERNA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 17.8% each year